Cardiovascular Diseases & Diagnosis

Director of Clinical Research, The Heart and Vascular Institute, Germantown, USA

Publications

• Expert Review   
  Is an Easy, Safe Management Strategy for the Life-Threatening Cardiac Complications of COVID-19 Right Under our Noses?
  Author(s): Gary L. Murray*
  
  Background: Many chronic conditions, as diabetes (DM) and cardiovascular Diseases, suffer Major Adverse Cardiac Events (MACE): i myocarditis, congestive heart failure (CHF), Ventricular Tachycardia (VT), Ventricular Fibrillation (VF), Acute Coronary Syndromes [ACSs], and Sudden Cardiac Death (SCD) Acute infections, like COVID-19, also involve oxidative stress, leading to increased Sympathetic tone (S) and decreased Parasympathetic tone (P), increasing Sympathovagal Balance (SB) and MACE. The antioxidant (r) alpha lipoic acid (ALA) improves SB. The anti-anginal Ranolazine (RAN), also an antioxidant, an anti-arrhythmic. Our studies of their effects on MACE, in DM, and non-DM patients with CHF, ventricular arrhythmias and SCD are reviewed herein, as our findings may apply to acute diseases, such as COVID-19. Methods: In a case-cont.. Read More»
  DOI: 10.37421/2329-9517.2021.9.461

  Abstract HTML PDF